nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—pancreatic cancer	0.838	1	CbGaD
Trisalicylate-choline—Magnesium salicylate—PTGS2—pancreatic cancer	0.00161	0.54	CrCbGaD
Trisalicylate-choline—Salsalate—PTGS2—pancreatic cancer	0.00137	0.46	CrCbGaD
Trisalicylate-choline—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.00128	0.00804	CcSEcCtD
Trisalicylate-choline—Hypothermia—Epirubicin—pancreatic cancer	0.00125	0.00785	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Epirubicin—pancreatic cancer	0.00125	0.00785	CcSEcCtD
Trisalicylate-choline—Weight increased—Tamoxifen—pancreatic cancer	0.00121	0.00764	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Sunitinib—pancreatic cancer	0.00121	0.00759	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Epirubicin—pancreatic cancer	0.0012	0.00757	CcSEcCtD
Trisalicylate-choline—Deafness—Gemcitabine—pancreatic cancer	0.00118	0.00746	CcSEcCtD
Trisalicylate-choline—Hypothermia—Doxorubicin—pancreatic cancer	0.00115	0.00726	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Doxorubicin—pancreatic cancer	0.00115	0.00726	CcSEcCtD
Trisalicylate-choline—Sweating—Tamoxifen—pancreatic cancer	0.00114	0.00717	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Doxorubicin—pancreatic cancer	0.00111	0.007	CcSEcCtD
Trisalicylate-choline—Epistaxis—Erlotinib—pancreatic cancer	0.00111	0.00698	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Sunitinib—pancreatic cancer	0.00109	0.00689	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Docetaxel—pancreatic cancer	0.00109	0.00685	CcSEcCtD
Trisalicylate-choline—Hepatitis—Tamoxifen—pancreatic cancer	0.00107	0.00672	CcSEcCtD
Trisalicylate-choline—Lethargy—Fluorouracil—pancreatic cancer	0.00106	0.00669	CcSEcCtD
Trisalicylate-choline—Hepatitis—Erlotinib—pancreatic cancer	0.00105	0.00664	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Docetaxel—pancreatic cancer	0.00103	0.00648	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00101	0.00635	CcSEcCtD
Trisalicylate-choline—Burning sensation—Epirubicin—pancreatic cancer	0.001	0.00633	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Erlotinib—pancreatic cancer	0.000997	0.00628	CcSEcCtD
Trisalicylate-choline—Flushing—Tamoxifen—pancreatic cancer	0.000989	0.00623	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Docetaxel—pancreatic cancer	0.000988	0.00623	CcSEcCtD
Trisalicylate-choline—Epistaxis—Sunitinib—pancreatic cancer	0.000959	0.00604	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Docetaxel—pancreatic cancer	0.000946	0.00596	CcSEcCtD
Trisalicylate-choline—Burning sensation—Doxorubicin—pancreatic cancer	0.00093	0.00586	CcSEcCtD
Trisalicylate-choline—Erythema—Tamoxifen—pancreatic cancer	0.000928	0.00585	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Docetaxel—pancreatic cancer	0.000926	0.00584	CcSEcCtD
Trisalicylate-choline—Erythema—Erlotinib—pancreatic cancer	0.000918	0.00578	CcSEcCtD
Trisalicylate-choline—Hepatitis—Sunitinib—pancreatic cancer	0.000913	0.00575	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Tamoxifen—pancreatic cancer	0.000909	0.00572	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Sunitinib—pancreatic cancer	0.000863	0.00544	CcSEcCtD
Trisalicylate-choline—Stinging—Epirubicin—pancreatic cancer	0.000862	0.00543	CcSEcCtD
Trisalicylate-choline—Flushing—Sunitinib—pancreatic cancer	0.000847	0.00534	CcSEcCtD
Trisalicylate-choline—Deafness—Docetaxel—pancreatic cancer	0.00084	0.00529	CcSEcCtD
Trisalicylate-choline—Sweating—Irinotecan—pancreatic cancer	0.000803	0.00506	CcSEcCtD
Trisalicylate-choline—Stinging—Doxorubicin—pancreatic cancer	0.000797	0.00502	CcSEcCtD
Trisalicylate-choline—Erythema—Sunitinib—pancreatic cancer	0.000795	0.00501	CcSEcCtD
Trisalicylate-choline—Sweating—Gemcitabine—pancreatic cancer	0.000782	0.00493	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Sunitinib—pancreatic cancer	0.000778	0.0049	CcSEcCtD
Trisalicylate-choline—Lethargy—Docetaxel—pancreatic cancer	0.000767	0.00483	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Epirubicin—pancreatic cancer	0.000763	0.00481	CcSEcCtD
Trisalicylate-choline—Oedema—Tamoxifen—pancreatic cancer	0.000757	0.00477	CcSEcCtD
Trisalicylate-choline—Epistaxis—Fluorouracil—pancreatic cancer	0.000757	0.00477	CcSEcCtD
Trisalicylate-choline—Oedema—Erlotinib—pancreatic cancer	0.000749	0.00472	CcSEcCtD
Trisalicylate-choline—Shock—Erlotinib—pancreatic cancer	0.000737	0.00464	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000732	0.00461	CcSEcCtD
Trisalicylate-choline—Anorexia—Tamoxifen—pancreatic cancer	0.000722	0.00455	CcSEcCtD
Trisalicylate-choline—Anorexia—Erlotinib—pancreatic cancer	0.000714	0.0045	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Doxorubicin—pancreatic cancer	0.000706	0.00445	CcSEcCtD
Trisalicylate-choline—Flushing—Irinotecan—pancreatic cancer	0.000698	0.0044	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Epirubicin—pancreatic cancer	0.000694	0.00437	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000693	0.00436	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Docetaxel—pancreatic cancer	0.000686	0.00432	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Epirubicin—pancreatic cancer	0.000667	0.0042	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Tamoxifen—pancreatic cancer	0.000667	0.0042	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Erlotinib—pancreatic cancer	0.000659	0.00416	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Tamoxifen—pancreatic cancer	0.000658	0.00415	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Erlotinib—pancreatic cancer	0.000651	0.0041	CcSEcCtD
Trisalicylate-choline—Oedema—Sunitinib—pancreatic cancer	0.000649	0.00409	CcSEcCtD
Trisalicylate-choline—Constipation—Tamoxifen—pancreatic cancer	0.000648	0.00408	CcSEcCtD
Trisalicylate-choline—Pain—Tamoxifen—pancreatic cancer	0.000648	0.00408	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Doxorubicin—pancreatic cancer	0.000642	0.00405	CcSEcCtD
Trisalicylate-choline—Pain—Erlotinib—pancreatic cancer	0.000641	0.00404	CcSEcCtD
Trisalicylate-choline—Constipation—Erlotinib—pancreatic cancer	0.000641	0.00404	CcSEcCtD
Trisalicylate-choline—Shock—Sunitinib—pancreatic cancer	0.000638	0.00402	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Epirubicin—pancreatic cancer	0.000638	0.00402	CcSEcCtD
Trisalicylate-choline—Erythema—Gemcitabine—pancreatic cancer	0.000638	0.00402	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Epirubicin—pancreatic cancer	0.000631	0.00398	CcSEcCtD
Trisalicylate-choline—Erythema—Fluorouracil—pancreatic cancer	0.000627	0.00395	CcSEcCtD
Trisalicylate-choline—Anorexia—Sunitinib—pancreatic cancer	0.000618	0.0039	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—pancreatic cancer	0.000617	0.00389	CcSEcCtD
Trisalicylate-choline—Urticaria—Tamoxifen—pancreatic cancer	0.000602	0.00379	CcSEcCtD
Trisalicylate-choline—Weight increased—Docetaxel—pancreatic cancer	0.000591	0.00372	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—pancreatic cancer	0.00059	0.00372	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—pancreatic cancer	0.000584	0.00368	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Sunitinib—pancreatic cancer	0.000571	0.0036	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Sunitinib—pancreatic cancer	0.000564	0.00355	CcSEcCtD
Trisalicylate-choline—Constipation—Sunitinib—pancreatic cancer	0.000555	0.00349	CcSEcCtD
Trisalicylate-choline—Pain—Sunitinib—pancreatic cancer	0.000555	0.00349	CcSEcCtD
Trisalicylate-choline—Epistaxis—Docetaxel—pancreatic cancer	0.000546	0.00344	CcSEcCtD
Trisalicylate-choline—Confusional state—Irinotecan—pancreatic cancer	0.000539	0.00339	CcSEcCtD
Trisalicylate-choline—Pruritus—Tamoxifen—pancreatic cancer	0.000536	0.00338	CcSEcCtD
Trisalicylate-choline—Oedema—Irinotecan—pancreatic cancer	0.000534	0.00337	CcSEcCtD
Trisalicylate-choline—Pruritus—Erlotinib—pancreatic cancer	0.00053	0.00334	CcSEcCtD
Trisalicylate-choline—Shock—Irinotecan—pancreatic cancer	0.000526	0.00331	CcSEcCtD
Trisalicylate-choline—Oedema—Gemcitabine—pancreatic cancer	0.00052	0.00328	CcSEcCtD
Trisalicylate-choline—Hepatitis—Docetaxel—pancreatic cancer	0.00052	0.00328	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Tamoxifen—pancreatic cancer	0.000518	0.00326	CcSEcCtD
Trisalicylate-choline—Lethargy—Epirubicin—pancreatic cancer	0.000517	0.00326	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000516	0.00325	CcSEcCtD
Trisalicylate-choline—Confusional state—Fluorouracil—pancreatic cancer	0.000516	0.00325	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Erlotinib—pancreatic cancer	0.000513	0.00323	CcSEcCtD
Trisalicylate-choline—Oedema—Fluorouracil—pancreatic cancer	0.000512	0.00322	CcSEcCtD
Trisalicylate-choline—Anorexia—Irinotecan—pancreatic cancer	0.000509	0.00321	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000503	0.00317	CcSEcCtD
Trisalicylate-choline—Dizziness—Tamoxifen—pancreatic cancer	0.000501	0.00316	CcSEcCtD
Trisalicylate-choline—Hypotension—Irinotecan—pancreatic cancer	0.000499	0.00315	CcSEcCtD
Trisalicylate-choline—Anorexia—Gemcitabine—pancreatic cancer	0.000496	0.00313	CcSEcCtD
Trisalicylate-choline—Dizziness—Erlotinib—pancreatic cancer	0.000495	0.00312	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Docetaxel—pancreatic cancer	0.000491	0.0031	CcSEcCtD
Trisalicylate-choline—Anorexia—Fluorouracil—pancreatic cancer	0.000488	0.00307	CcSEcCtD
Trisalicylate-choline—Hypotension—Gemcitabine—pancreatic cancer	0.000486	0.00306	CcSEcCtD
Trisalicylate-choline—Flushing—Docetaxel—pancreatic cancer	0.000482	0.00304	CcSEcCtD
Trisalicylate-choline—Vomiting—Tamoxifen—pancreatic cancer	0.000481	0.00303	CcSEcCtD
Trisalicylate-choline—Lethargy—Doxorubicin—pancreatic cancer	0.000479	0.00302	CcSEcCtD
Trisalicylate-choline—Hypotension—Fluorouracil—pancreatic cancer	0.000478	0.00301	CcSEcCtD
Trisalicylate-choline—Rash—Tamoxifen—pancreatic cancer	0.000477	0.00301	CcSEcCtD
Trisalicylate-choline—Dermatitis—Tamoxifen—pancreatic cancer	0.000477	0.00301	CcSEcCtD
Trisalicylate-choline—Vomiting—Erlotinib—pancreatic cancer	0.000476	0.003	CcSEcCtD
Trisalicylate-choline—Somnolence—Irinotecan—pancreatic cancer	0.000475	0.00299	CcSEcCtD
Trisalicylate-choline—Headache—Tamoxifen—pancreatic cancer	0.000474	0.00299	CcSEcCtD
Trisalicylate-choline—Rash—Erlotinib—pancreatic cancer	0.000472	0.00298	CcSEcCtD
Trisalicylate-choline—Dermatitis—Erlotinib—pancreatic cancer	0.000472	0.00297	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Irinotecan—pancreatic cancer	0.00047	0.00296	CcSEcCtD
Trisalicylate-choline—Headache—Erlotinib—pancreatic cancer	0.000469	0.00296	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Irinotecan—pancreatic cancer	0.000464	0.00293	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000463	0.00292	CcSEcCtD
Trisalicylate-choline—Somnolence—Gemcitabine—pancreatic cancer	0.000463	0.00292	CcSEcCtD
Trisalicylate-choline—Pruritus—Sunitinib—pancreatic cancer	0.000459	0.00289	CcSEcCtD
Trisalicylate-choline—Pain—Irinotecan—pancreatic cancer	0.000457	0.00288	CcSEcCtD
Trisalicylate-choline—Constipation—Irinotecan—pancreatic cancer	0.000457	0.00288	CcSEcCtD
Trisalicylate-choline—Somnolence—Fluorouracil—pancreatic cancer	0.000455	0.00287	CcSEcCtD
Trisalicylate-choline—Erythema—Docetaxel—pancreatic cancer	0.000452	0.00285	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Gemcitabine—pancreatic cancer	0.000452	0.00285	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Fluorouracil—pancreatic cancer	0.00045	0.00284	CcSEcCtD
Trisalicylate-choline—Nausea—Tamoxifen—pancreatic cancer	0.00045	0.00283	CcSEcCtD
Trisalicylate-choline—Constipation—Gemcitabine—pancreatic cancer	0.000445	0.0028	CcSEcCtD
Trisalicylate-choline—Pain—Gemcitabine—pancreatic cancer	0.000445	0.0028	CcSEcCtD
Trisalicylate-choline—Nausea—Erlotinib—pancreatic cancer	0.000445	0.0028	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Fluorouracil—pancreatic cancer	0.000445	0.0028	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Sunitinib—pancreatic cancer	0.000444	0.0028	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Docetaxel—pancreatic cancer	0.000443	0.00279	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Irinotecan—pancreatic cancer	0.00044	0.00277	CcSEcCtD
Trisalicylate-choline—Asthma—Epirubicin—pancreatic cancer	0.000438	0.00276	CcSEcCtD
Trisalicylate-choline—Pain—Fluorouracil—pancreatic cancer	0.000438	0.00276	CcSEcCtD
Trisalicylate-choline—Dizziness—Sunitinib—pancreatic cancer	0.000429	0.0027	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000429	0.0027	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000428	0.0027	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000422	0.00266	CcSEcCtD
Trisalicylate-choline—Vomiting—Sunitinib—pancreatic cancer	0.000412	0.0026	CcSEcCtD
Trisalicylate-choline—Rash—Sunitinib—pancreatic cancer	0.000409	0.00258	CcSEcCtD
Trisalicylate-choline—Dermatitis—Sunitinib—pancreatic cancer	0.000409	0.00257	CcSEcCtD
Trisalicylate-choline—Urticaria—Fluorouracil—pancreatic cancer	0.000406	0.00256	CcSEcCtD
Trisalicylate-choline—Headache—Sunitinib—pancreatic cancer	0.000406	0.00256	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—pancreatic cancer	0.000405	0.00255	CcSEcCtD
Trisalicylate-choline—Weight increased—Epirubicin—pancreatic cancer	0.000399	0.00251	CcSEcCtD
Trisalicylate-choline—Drowsiness—Epirubicin—pancreatic cancer	0.000391	0.00246	CcSEcCtD
Trisalicylate-choline—Nausea—Sunitinib—pancreatic cancer	0.000385	0.00243	CcSEcCtD
Trisalicylate-choline—Sweating—Epirubicin—pancreatic cancer	0.000374	0.00236	CcSEcCtD
Trisalicylate-choline—Confusional state—Docetaxel—pancreatic cancer	0.000372	0.00235	CcSEcCtD
Trisalicylate-choline—Oedema—Docetaxel—pancreatic cancer	0.000369	0.00233	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—pancreatic cancer	0.000369	0.00232	CcSEcCtD
Trisalicylate-choline—Epistaxis—Epirubicin—pancreatic cancer	0.000368	0.00232	CcSEcCtD
Trisalicylate-choline—Pruritus—Gemcitabine—pancreatic cancer	0.000368	0.00232	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Irinotecan—pancreatic cancer	0.000366	0.0023	CcSEcCtD
Trisalicylate-choline—Shock—Docetaxel—pancreatic cancer	0.000363	0.00229	CcSEcCtD
Trisalicylate-choline—Pruritus—Fluorouracil—pancreatic cancer	0.000362	0.00228	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—pancreatic cancer	0.000361	0.00228	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Gemcitabine—pancreatic cancer	0.000356	0.00224	CcSEcCtD
Trisalicylate-choline—Dizziness—Irinotecan—pancreatic cancer	0.000353	0.00223	CcSEcCtD
Trisalicylate-choline—Anorexia—Docetaxel—pancreatic cancer	0.000352	0.00222	CcSEcCtD
Trisalicylate-choline—Hepatitis—Epirubicin—pancreatic cancer	0.000351	0.00221	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Fluorouracil—pancreatic cancer	0.00035	0.00221	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—pancreatic cancer	0.000346	0.00218	CcSEcCtD
Trisalicylate-choline—Hypotension—Docetaxel—pancreatic cancer	0.000345	0.00217	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—pancreatic cancer	0.000341	0.00215	CcSEcCtD
Trisalicylate-choline—Vomiting—Irinotecan—pancreatic cancer	0.00034	0.00214	CcSEcCtD
Trisalicylate-choline—Dizziness—Fluorouracil—pancreatic cancer	0.000338	0.00213	CcSEcCtD
Trisalicylate-choline—Rash—Irinotecan—pancreatic cancer	0.000337	0.00212	CcSEcCtD
Trisalicylate-choline—Dermatitis—Irinotecan—pancreatic cancer	0.000337	0.00212	CcSEcCtD
Trisalicylate-choline—Headache—Irinotecan—pancreatic cancer	0.000335	0.00211	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Epirubicin—pancreatic cancer	0.000332	0.00209	CcSEcCtD
Trisalicylate-choline—Vomiting—Gemcitabine—pancreatic cancer	0.000331	0.00208	CcSEcCtD
Trisalicylate-choline—Somnolence—Docetaxel—pancreatic cancer	0.000328	0.00207	CcSEcCtD
Trisalicylate-choline—Rash—Gemcitabine—pancreatic cancer	0.000328	0.00207	CcSEcCtD
Trisalicylate-choline—Dermatitis—Gemcitabine—pancreatic cancer	0.000328	0.00207	CcSEcCtD
Trisalicylate-choline—Tinnitus—Epirubicin—pancreatic cancer	0.000327	0.00206	CcSEcCtD
Trisalicylate-choline—Headache—Gemcitabine—pancreatic cancer	0.000326	0.00205	CcSEcCtD
Trisalicylate-choline—Flushing—Epirubicin—pancreatic cancer	0.000325	0.00205	CcSEcCtD
Trisalicylate-choline—Vomiting—Fluorouracil—pancreatic cancer	0.000325	0.00205	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Docetaxel—pancreatic cancer	0.000325	0.00205	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—pancreatic cancer	0.000324	0.00204	CcSEcCtD
Trisalicylate-choline—Rash—Fluorouracil—pancreatic cancer	0.000323	0.00203	CcSEcCtD
Trisalicylate-choline—Dermatitis—Fluorouracil—pancreatic cancer	0.000322	0.00203	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Docetaxel—pancreatic cancer	0.000321	0.00202	CcSEcCtD
Trisalicylate-choline—Headache—Fluorouracil—pancreatic cancer	0.000321	0.00202	CcSEcCtD
Trisalicylate-choline—Nausea—Irinotecan—pancreatic cancer	0.000317	0.002	CcSEcCtD
Trisalicylate-choline—Pain—Docetaxel—pancreatic cancer	0.000316	0.00199	CcSEcCtD
Trisalicylate-choline—Constipation—Docetaxel—pancreatic cancer	0.000316	0.00199	CcSEcCtD
Trisalicylate-choline—Nausea—Gemcitabine—pancreatic cancer	0.000309	0.00195	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000307	0.00193	CcSEcCtD
Trisalicylate-choline—Erythema—Epirubicin—pancreatic cancer	0.000305	0.00192	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Docetaxel—pancreatic cancer	0.000304	0.00192	CcSEcCtD
Trisalicylate-choline—Nausea—Fluorouracil—pancreatic cancer	0.000304	0.00191	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—pancreatic cancer	0.000302	0.00191	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—pancreatic cancer	0.000301	0.0019	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Epirubicin—pancreatic cancer	0.000299	0.00188	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—pancreatic cancer	0.000282	0.00178	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—pancreatic cancer	0.000277	0.00174	CcSEcCtD
Trisalicylate-choline—Pruritus—Docetaxel—pancreatic cancer	0.000261	0.00165	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Docetaxel—pancreatic cancer	0.000253	0.00159	CcSEcCtD
Trisalicylate-choline—Confusional state—Epirubicin—pancreatic cancer	0.000251	0.00158	CcSEcCtD
Trisalicylate-choline—Oedema—Epirubicin—pancreatic cancer	0.000249	0.00157	CcSEcCtD
Trisalicylate-choline—Shock—Epirubicin—pancreatic cancer	0.000245	0.00154	CcSEcCtD
Trisalicylate-choline—Dizziness—Docetaxel—pancreatic cancer	0.000244	0.00154	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000241	0.00152	CcSEcCtD
Trisalicylate-choline—Anorexia—Epirubicin—pancreatic cancer	0.000237	0.0015	CcSEcCtD
Trisalicylate-choline—Vomiting—Docetaxel—pancreatic cancer	0.000235	0.00148	CcSEcCtD
Trisalicylate-choline—Rash—Docetaxel—pancreatic cancer	0.000233	0.00147	CcSEcCtD
Trisalicylate-choline—Hypotension—Epirubicin—pancreatic cancer	0.000233	0.00147	CcSEcCtD
Trisalicylate-choline—Dermatitis—Docetaxel—pancreatic cancer	0.000233	0.00147	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—pancreatic cancer	0.000232	0.00146	CcSEcCtD
Trisalicylate-choline—Headache—Docetaxel—pancreatic cancer	0.000231	0.00146	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—pancreatic cancer	0.00023	0.00145	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—pancreatic cancer	0.000227	0.00143	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000223	0.0014	CcSEcCtD
Trisalicylate-choline—Somnolence—Epirubicin—pancreatic cancer	0.000221	0.0014	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—pancreatic cancer	0.00022	0.00138	CcSEcCtD
Trisalicylate-choline—Nausea—Docetaxel—pancreatic cancer	0.000219	0.00138	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Epirubicin—pancreatic cancer	0.000219	0.00138	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Epirubicin—pancreatic cancer	0.000217	0.00136	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—pancreatic cancer	0.000215	0.00136	CcSEcCtD
Trisalicylate-choline—Pain—Epirubicin—pancreatic cancer	0.000213	0.00134	CcSEcCtD
Trisalicylate-choline—Constipation—Epirubicin—pancreatic cancer	0.000213	0.00134	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Epirubicin—pancreatic cancer	0.000205	0.00129	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—pancreatic cancer	0.000205	0.00129	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Doxorubicin—pancreatic cancer	0.000203	0.00128	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—pancreatic cancer	0.0002	0.00126	CcSEcCtD
Trisalicylate-choline—Urticaria—Epirubicin—pancreatic cancer	0.000198	0.00125	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—pancreatic cancer	0.000197	0.00124	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—pancreatic cancer	0.000197	0.00124	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00019	0.0012	CcSEcCtD
Trisalicylate-choline—Urticaria—Doxorubicin—pancreatic cancer	0.000183	0.00115	CcSEcCtD
Trisalicylate-choline—Pruritus—Epirubicin—pancreatic cancer	0.000176	0.00111	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Epirubicin—pancreatic cancer	0.00017	0.00107	CcSEcCtD
Trisalicylate-choline—Dizziness—Epirubicin—pancreatic cancer	0.000165	0.00104	CcSEcCtD
Trisalicylate-choline—Pruritus—Doxorubicin—pancreatic cancer	0.000163	0.00103	CcSEcCtD
Trisalicylate-choline—Vomiting—Epirubicin—pancreatic cancer	0.000158	0.000998	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Doxorubicin—pancreatic cancer	0.000158	0.000994	CcSEcCtD
Trisalicylate-choline—Rash—Epirubicin—pancreatic cancer	0.000157	0.00099	CcSEcCtD
Trisalicylate-choline—Dermatitis—Epirubicin—pancreatic cancer	0.000157	0.000989	CcSEcCtD
Trisalicylate-choline—Headache—Epirubicin—pancreatic cancer	0.000156	0.000983	CcSEcCtD
Trisalicylate-choline—Dizziness—Doxorubicin—pancreatic cancer	0.000152	0.00096	CcSEcCtD
Trisalicylate-choline—Nausea—Epirubicin—pancreatic cancer	0.000148	0.000932	CcSEcCtD
Trisalicylate-choline—Vomiting—Doxorubicin—pancreatic cancer	0.000147	0.000923	CcSEcCtD
Trisalicylate-choline—Rash—Doxorubicin—pancreatic cancer	0.000145	0.000916	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—pancreatic cancer	0.000145	0.000915	CcSEcCtD
Trisalicylate-choline—Headache—Doxorubicin—pancreatic cancer	0.000144	0.00091	CcSEcCtD
Trisalicylate-choline—Nausea—Doxorubicin—pancreatic cancer	0.000137	0.000863	CcSEcCtD
